Pharma
North Carolina’s Research Triangle sees big investments despite NIH cuts
Johnson & Johnson, Amgen, and Fujifilm Biotechnologies have all recently invested in the RTP.
Biotech & Emerging Modalities
Deep dives into Biotech & Emerging Modalities and its impact on healthcare. From Biosimilars and RNA Therapeutics to industry-wide shifts, Healthcare Brew covers the essential developments in Pharma.
Pharma
New and notable treatments from 2025
From HIV to opioids, 2025 brought solutions to some of the world’s most pressing health issues.
Pharma
What 23andMe’s Regeneron sale means for the industry
This completes the company’s yearslong fall from its $6 billion peak.
Pharma
Johns Hopkins mRNA researchers rattled by potential cuts
Cuts to research funding could harm efforts to develop a vaccine for pancreatic cancer.
Pharma
Duchenne community mourns patient death, but largely stands behind Elevidys gene therapy
A 16-year-old’s death has ignited a debate around gene therapy and led to a pause of European trials.
Pharma
3 major biotechs make acquisitions
J&J, Eli Lilly, and GSK all made deals on Monday morning.
Pharma
Gene and Cell Therapy Institute seeks to fight rare diseases
The institute, based out of Mass General Brigham, is trying to get new treatments to patients faster.
Navigate the healthcare industry
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.
